Latest Articles
Glypican3 and serglycin as potential biomarkers involved in the pathogenesis of ovarian endometriosis.
Endometriosis, a non-malignant gynecological disorder characterized by debilitating symptoms, displays several cancer-like characteristics, including metastatic behavior and extracellular matrix (ECM) remodeling. The dynamics of ECM are largely influenced by proteoglycans …
Published: March 20, 2025, midnight
AI model detects endometrial cancer at almost 100 per cent accuracy - NT News
AI model detects endometrial cancer at almost 100 per cent accuracy NT News
Published: March 19, 2025, 3:45 p.m.
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı
Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı
Published: March 19, 2025, 2:55 p.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - MSN
Investigational ADC Shows Promise in Advanced Endometrial Cancer MSN
Published: March 19, 2025, 1:18 a.m.
Investigational ADC Shows Promise in Advanced Endometrial Cancer - Medpage Today
Investigational ADC Shows Promise in Advanced Endometrial Cancer Medpage Today
Published: March 18, 2025, 8:07 p.m.
The Importance of Spotting Endometrial Cancer - Curetoday.com
The Importance of Spotting Endometrial Cancer Curetoday.com
Published: March 18, 2025, 3:24 p.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - OBR Oncology
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups OBR Oncology
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - Oncology News Central
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups Oncology News Central
Published: March 18, 2025, 10:24 a.m.
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups - oncologynewscentral.com
Adding Olaparib (Lynparza) to Durvalumab (Imfinzi) Shows Benefit in Endometrial Cancer Subgroups oncologynewscentral.com
Published: March 18, 2025, 10:24 a.m.
(PDF) Association Between Hepatic Steatosis Index and Endometrial Cancer Risk: A Cross-Sectional Study - ResearchGate
(PDF) Association Between Hepatic Steatosis Index and Endometrial Cancer Risk: A Cross-Sectional Study ResearchGate
Published: March 18, 2025, 5:59 a.m.
Link copied to clipboard!